ERNANasdaqPharmaceutical Preparations

Ernexa Therapeutics Inc. (ERNA) earnings date, market-implied expected move, and options open interest by expiry

1.95

−0.07 · −3.47%

post 1.94 −0.51%

After hours16:10 ETdelayed

Open1.94Volume11,373Mkt cap$3.3M

Day1.94 – 1.9450%52-wk1.84 – 47.250%

ERNA

Ernexa Therapeutics Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 12

before open · in 8 days

est.Q3 FY26

Calendar

Next report

Last report

—

Largest filed tie

—

13F top-10 QoQ

−96.99%

shares held · 5 largest managers

13F · Jun 30 '26127d lag

Top fund weight

—

Ernexa Therapeutics (ERNA) is expected to report on Nov 12 before open (estimated date).

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

derived from FYQ4 FY24

−575900.00%derived from FYnet margin · revenue −99.79% QoQ · −94.12% YoY

Revenue$1,000−99.79%

Gross profit$1,000100.00%−99.82%

Operating income−$3M−269700.00%−19.39%

Pre-tax income−$6M+78.38%

Net income−$6M−575900.00%+78.35%

Operating expenses$3M−3.85%

Tax$11,000−8.33%

Other expense−$3M+87.46%

Derived: FY − Q1–Q3 · QE Dec 31 '24 · bars = % of revenue

Revenue flow

Intraday

No trades yet today.

Intraday

Event sensitivity

CPI ×2.19· ±11.3% vs ±5.2% · 10 releases

eventrelease day|move|up · n×base

CPIconsumer prices±11.3%5 of 10×2.19

PCEpersonal income & outlays±6.7%10 of 19×1.30

FOMCrate decision±5.5%10 of 24×1.06

GDPgross domestic product±5.5%8 of 19×1.06

NFPjobs report±3.8%1 of 10×0.73

CPROFcorporate profits±3.6%5 of 12×0.70

PPIproducer prices±3.1%7 of 10×0.60

Bar = avg |move| to ±12% · tick = ±5.2% avg day · ×base = |move| ÷ ±5.2% · min 6 releases

Earnings history

EPS -3.40 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	—	-3.40	—
Q1 FY26	—	-6.95	—
Q3 FY25	—	-0.15	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod